Treatment for Bronchitis
Acute Bronchitis: Avoid Antibiotics
For acute bronchitis in otherwise healthy adults, antibiotics should NOT be prescribed, as viruses cause more than 90% of cases and antibiotics provide minimal benefit (reducing cough by only half a day) while causing adverse effects. 1, 2, 3, 4
Symptomatic Management for Acute Bronchitis
Set realistic expectations: Inform patients their cough will typically last 10-14 days after the visit, with total duration of 2-3 weeks 5, 4
Use the term "chest cold" rather than "bronchitis" when discussing the illness, as this terminology reduces patient expectations for antibiotics 5, 2
Consider short-acting β-agonists (albuterol) for patients with evidence of bronchial hyperresponsiveness or wheezing, which may reduce cough duration and severity 1, 2
Ipratropium bromide may improve cough in some patients with acute bronchitis 1, 2
Dextromethorphan or codeine can provide short-term symptomatic relief for bothersome cough, though evidence shows modest effect 5, 1, 2
Environmental modifications: Remove irritants (dust, dander) and consider vaporized air treatments, particularly in low-humidity environments 5
When to Consider Antibiotics in Acute Bronchitis
- Only if pertussis is suspected to reduce transmission 3
- Only for patients at increased risk of pneumonia (age ≥65 years) 3
- Rule out pneumonia first by assessing for tachycardia, tachypnea, fever, and abnormal chest examination findings 2
Chronic Bronchitis: Stepwise Bronchodilator Approach
Smoking cessation is the cornerstone of therapy, with 90% of patients experiencing resolution of cough after quitting. 1, 2
Stable Chronic Bronchitis Treatment Algorithm
First-line: Short-acting β-agonists to control bronchospasm and reduce chronic cough (Grade A recommendation) 5, 1, 2
Add ipratropium bromide to improve cough if β-agonists alone are insufficient (Grade A recommendation) 5, 1, 2
Consider theophylline for chronic cough control in stable patients, though careful monitoring for complications is necessary (Grade A recommendation) 5
For severe airflow obstruction (FEV₁ <50%) or frequent exacerbations: Add long-acting β-agonist combined with inhaled corticosteroid 5, 1, 2
Treatments NOT Recommended for Stable Chronic Bronchitis
- Expectorants and mucolytics lack evidence of benefit 1, 2
- Long-term prophylactic antibiotics are not recommended 1, 2
- Oral corticosteroids have no proven benefit in stable patients and carry significant side effects 5
Acute Exacerbations of Chronic Bronchitis: Antibiotics ARE Indicated
For acute exacerbations, prescribe antibiotics for patients with at least 2 of 3 cardinal symptoms (increased dyspnea, increased sputum production, increased sputum purulence) AND at least one risk factor. 6
Risk Factors Requiring Antibiotic Treatment
- Age ≥65 years 6
- FEV₁ <50% of predicted value 6
- ≥4 exacerbations in 12 months 6
- One or more comorbidities 6
Antibiotic Selection for Acute Exacerbations
For moderate severity exacerbations: Newer macrolide (azithromycin), extended-spectrum cephalosporin, or doxycycline 6
For severe exacerbations or high-risk patients (age >65, severe obstruction, recurrent exacerbations): High-dose amoxicillin/clavulanate or respiratory fluoroquinolone 7, 6
- Azithromycin 500 mg once daily for 3 days showed 85% clinical cure rate at Day 21-24 for acute exacerbations 8
Additional Management for Acute Exacerbations
Bronchodilators: Administer short-acting β-agonists or anticholinergic bronchodilators; if no prompt response, add the other agent after maximizing the first (Grade A recommendation) 5, 1, 2
Systemic corticosteroids: A short course (10-15 days) is effective for acute exacerbations 1, 2
DO NOT use theophylline for acute exacerbations (Grade D recommendation) 5, 1, 2
Common Pitfalls to Avoid
Do not prescribe antibiotics based solely on colored sputum, as this does not reliably differentiate bacterial from viral infection 2, 3
Do not confuse acute bronchitis with pneumonia—always assess vital signs and lung examination before diagnosing uncomplicated bronchitis 2
Do not use expectorants or mucolytics, which lack evidence of benefit for either acute or chronic bronchitis 1, 2
Avoid prophylactic antibiotics in stable chronic bronchitis patients 1, 2
Communicate effectively about the natural course of illness and lack of antibiotic benefit to maintain patient satisfaction without inappropriate prescribing 5, 4